Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry.
Daudén E, Carretero G, Rivera R, Ferrándiz C, Llamas-Velasco M, de la Cueva P, Belinchón I, Gómez-García FJ, Herrera-Acosta E, Ruiz-Genao DP, Ferrán-Farrés M, Alsina M, Baniandrés-Rodríguez O, Sánchez-Carazo JL, Sahuquillo-Torralba A, Fernández-Freire LR, Vilar-Alejo J, García-Donoso C, Carrascosa JM, Herrera-Ceballos E, López-Estebaranz JL, Botella-Estrada R, Segovia-Muñoz E, Descalzo MA, García-Doval I; BIOBADADERM Study Group. Daudén E, et al. Among authors: alsina m. J Am Acad Dermatol. 2020 Jul;83(1):139-150. doi: 10.1016/j.jaad.2020.03.033. Epub 2020 Mar 22. J Am Acad Dermatol. 2020. PMID: 32213306 Free article.
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
Baniandrés-Rodríguez O, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, Sahuquillo-Torralba A, Gómez-García FJ, Nieto-Benito LM, de la Cueva P, López-Estebaranz JL, Belinchón I, Ferrán Farrés M, Alsina M, Fernández-Freire LR, Carretero G, García-Donoso C, Ballescá F, Llamas-Velasco M, Herrera-Ceballos E, Botella-Estrada R, Ruiz-Genao DP, Riera-Monroig J, Descalzo Gallego MÁ, García-Doval I; BIOBADADERM Study Group. Baniandrés-Rodríguez O, et al. Among authors: alsina m. J Am Acad Dermatol. 2021 Feb;84(2):513-517. doi: 10.1016/j.jaad.2020.10.046. Epub 2020 Oct 26. J Am Acad Dermatol. 2021. PMID: 33122022 Free PMC article. No abstract available.
[Adverse reactions during biological therapy for psoriasis: results of a survey of the Spanish Psoriasis Group].
Sánchez-Regaña M, Dilmé E, Puig L, Bordas X, Carrascosa JM, Ferran M, Herranz P, García-Bustinduy M, López Estebaranz JL, Alsina M, Rodríguez MA, Ribera M, Fernández-López E, Moreno JC, Belinchón Romero I, Vidal D; Grupo Español de Psoriasis de la Academia Española. Sánchez-Regaña M, et al. Among authors: alsina m. Actas Dermosifiliogr. 2010 Mar;101(2):156-63. Actas Dermosifiliogr. 2010. PMID: 20223158 Spanish.
Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population.
Gonzalez-Cantero A, Carretero G, Rivera R, Ferrándiz C, Daudén E, de la Cueva P, Gómez-García FJ, Belinchón I, Herrera-Ceballos E, Ruiz-Genao D, Ferrán M, Alsina M, Sánchez-Carazo JL, Baniandrés O, Sahuquillo-Torralba A, Rodriguez L, Vilar J, García C, Carrascosa JM, Llamas-Velasco M, Herrera-Acosta E, López-Estebaranz JL, Botella-Estrada R, Descalzo MA, García-Doval I; BIOBADADERM Study Group. Gonzalez-Cantero A, et al. Among authors: alsina m. Br J Dermatol. 2019 Nov;181(5):1085-1087. doi: 10.1111/bjd.18164. Epub 2019 Aug 13. Br J Dermatol. 2019. PMID: 31127858 No abstract available.
High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting.
Martos-Cabrera L, Llamas-Velasco M, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, Rivera-Diaz R, de la Cueva P, Martorell-Calatayud A, Ballescá F, Belinchón I, Carretero G, Rodríguez L, Romero-Maté A, Pujol-Montcusí J, Salgado-Boquete L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés O, Feltes R, Alsina M, Daudén E. Martos-Cabrera L, et al. Among authors: alsina m. Int J Dermatol. 2023 Mar;62(3):e146-e149. doi: 10.1111/ijd.16365. Epub 2022 Jul 22. Int J Dermatol. 2023. PMID: 35867958 No abstract available.
Gold: an old drug still working in refractory pemphigus.
Iranzo P, Alsina MM, Martínez-De Pablo I, Segura S, Mascaró JM, Herrero C. Iranzo P, et al. Among authors: alsina mm. J Eur Acad Dermatol Venereol. 2007 Aug;21(7):902-7. doi: 10.1111/j.1468-3083.2006.02074.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17658998
[Reactions to infliximab infusions in dermatologic patients: consensus statement and treatment protocol. Working Group of the Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología ].
Puig Sanz L, Sáez E, Lozano MJ, Bordas X, Carrascosa JM, Gallardo F, Luelmo J, Sánchez-Regaña M, Alsina M, García-Patos V; Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología. Puig Sanz L, et al. Among authors: alsina m. Actas Dermosifiliogr. 2009 Mar;100(2):103-12. doi: 10.1016/s0001-7310(09)70227-3. Actas Dermosifiliogr. 2009. PMID: 19445874 Review. Spanish.
487 results